Abstract：Objective To investigate the effect of Banxia Baizhu Tianma Decoction combined with Edaravone in the treatment of acute ischemic stroke.Methods A total of 100 patients with acute ischemic stroke admitted to our hospital from May 2015 to May 2017 were selected as objects and randomly divided into the control group (50 cases)and the study group (50 cases).The control group was treated with Edaravone,while the study group was treated with Banxia Baizhu Tianma Decoction on the basis of the control group.The clinical efficacy,NIH stroke scale(NIHSS)scores and activity of daily living scale(ADL)scores before and after treatment in two groups were compared.Results The total effective rate of treatment in the study group (98.00%)was significantly higher than that in the control group (82.00%),and the difference was statistically significant(P＜0.05).There were no significant difference in NIHSS scores and ADL scores before treatment between two groups(P＞0.05).The NIHSS scores after treatment in the study group and control group ([10.65±1.55]points,[17.60±1.78]points)were respectively lower than those before treatment([25.02±2.60]points,[25.05±2.55]points),ADL scores([40.10±12.12]points,[36.55±11.95]points)after treatment were respectively higher than those before treatment([17.45±1.73]points,[17.40±1.78]points),and the differences were statistically significant(P＜0.05).The NIHSS scores after treatment in the study group were lower than those in the control group,and the difference was statistically significant(P＜0.05).There was no significant difference in ADL scores after treatment between the study group and the control group (P＞0.05).Conclusion Banxia Baizhu Tianma Decoction combined with Edaravone in the treatment of acute ischemic stroke is effective,and the symptoms of the disease after treatment are improved more significantly.
京公网安备 11010502046607号